Consumption of Whole Grains and Legumes Modulates the Genetic Effect of the APOA5 -1131C Variant
Not Applicable
Completed
- Conditions
- Subjects With Mild Hypertriglyceridemia in Type 2 DM
- Interventions
- Dietary Supplement: Dietary intervention
- Registration Number
- NCT01784952
- Lead Sponsor
- Yonsei University
- Brief Summary
We examined whether a substitution of whole grains and legumes for refined rice in a high carbohydrate diet (about 65% of energy derived from carbohydrate) may modify the effect of this variant on changes in apolipoprotein A-V (apoA-V) and triglyceride concentrations.
- Detailed Description
We genotyped the APOA5 -1131T\>C in individuals with impaired fasting glucose (IFG) or newly diagnosed type 2 diabetes, who were randomly assigned to either a group ingesting whole grain and legume meals daily or a control group for 12 weeks.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Subjects who were in in impaired fasting glucose (IFG, 100≤ fasting glucose <126 mg/dL) and newly diagnosed type 2 diabetes (fasting glucose ≥126 mg/dL) were referred to the Department of Family Medicine or Internal Medicine. They were rechecked for their health and lipid profiles, and then those who satisfied the study criteria were recommended to participate in the dietary intervention program
Read More
Exclusion Criteria
- Current and/or past history of cardiovascular disease including angina
- Liver or kidney dysfunction
- Thyroid or pituitary disease
- Unstable weight loss/gain (≥2 kg) over the previous 6months
- Pregnancy or lactation. Subjects who were taking medication were also excluded
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Whole grains and lequmes Dietary intervention - refined rice Dietary intervention -
- Primary Outcome Measures
Name Time Method Triglyceride change from baseline in TG at 12 weeks
- Secondary Outcome Measures
Name Time Method Apolipoprotein A5 Change from baseline in ApoA5 at 12 weeks
Trial Locations
- Locations (1)
Yonsei university
🇰🇷Seoul, Korea, Republic of